Fulcrum Asset Management LLP lifted its holdings in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 4,634.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,030 shares of the company’s stock after buying an additional 2,966 shares during the period. Fulcrum Asset Management LLP’s holdings in Molina Healthcare were worth $574,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in MOH. Allspring Global Investments Holdings LLC lifted its holdings in shares of Molina Healthcare by 6.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,677 shares of the company’s stock worth $303,000 after purchasing an additional 100 shares during the period. Hohimer Wealth Management LLC purchased a new position in Molina Healthcare in the 3rd quarter valued at $640,000. Ethic Inc. increased its stake in Molina Healthcare by 2.5% in the 3rd quarter. Ethic Inc. now owns 6,526 shares of the company’s stock valued at $1,234,000 after buying an additional 157 shares during the period. W.G. Shaheen & Associates DBA Whitney & Co increased its stake in Molina Healthcare by 1.9% in the 3rd quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 78,102 shares of the company’s stock valued at $14,769,000 after buying an additional 1,441 shares during the period. Finally, Privium Fund Management B.V. increased its stake in Molina Healthcare by 36.4% in the 3rd quarter. Privium Fund Management B.V. now owns 4,064 shares of the company’s stock valued at $769,000 after buying an additional 1,085 shares during the period. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently issued reports on MOH. UBS Group increased their price target on shares of Molina Healthcare from $202.00 to $225.00 and gave the stock a “neutral” rating in a report on Friday, October 23rd. Wells Fargo & Company lowered their price objective on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a report on Tuesday, July 28th. Zacks Research cut Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 12th. Royal Bank Of Canada increased their target price on Molina Healthcare from $218.00 to $222.00 and gave the stock a “sector perform” rating in a research note on Friday, October 23rd. Finally, Mizuho set a $255.00 price target on Molina Healthcare in a report on Friday, October 23rd. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and an average price target of $213.88.
Read Our Latest Research Report on Molina Healthcare
Insider Activity
In other news, insider Jeff Barlow sold 8,000 shares of the business’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $203.07, for a total transaction of $1,624,560.00. Following the transaction, the insider directly owned 59,313 shares of the company’s stock, valued at approximately $12,044,690.91. The trade was a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Dale Wolf sold 1,600 shares of the business’s stock in a transaction on Friday, November 13th. The stock was sold at an average price of $206.12, for a total transaction of $329,792.00. Following the completion of the transaction, the director owned 14,337 shares in the company, valued at $2,955,142.44. This represents a 10.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 10,382 shares of company stock worth $2,113,833. 1.44% of the stock is currently owned by corporate insiders.
Trending Headlines about Molina Healthcare
These are some of the MOH headlines that stood out recently:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $9.55 from $9.24 and FY2028 estimate to $12.44 from $12.19, alongside increases to several quarterly forecasts. These upgrades point to improved longer-term earnings expectations, although Zacks kept its rating at Hold. Molina Healthcare analyst estimates
- Neutral Sentiment: The FY2026 EPS estimate edged up to $5.27 from $5.25, but remains slightly below the cited $5.30 consensus. Zacks Research FY2026 earnings forecast
- Negative Sentiment: Insiders reported stock sales, including Director Richard Schapiro’s sale of 782 shares for about $159,000 and a separate report that the company’s legal chief sold about $1.62 million of stock. Insider sales can concern investors, though they do not by themselves indicate deteriorating business fundamentals. Richard Schapiro stock sale Molina legal chief stock sale
Molina Healthcare Stock Down 0.1%
MOH stock opened at $209.37 on Monday. The company has a 50 day moving average price of $202.56 and a two-hundred day moving average price of $185.69. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.69 and a current ratio of 1.69. The stock has a market capitalization of $10.93 billion, a P/E ratio of -218.09, a PEG ratio of 12.35 and a beta of 0.74. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $244.89.
Molina Healthcare (NYSE:MOH – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The firm had revenue of $11.08 billion during the quarter, compared to analyst estimates of $10.86 billion. During the same quarter in the prior year, the business posted $1.84 earnings per share. Molina Healthcare’s revenue for the quarter was down 3.4% compared to the same quarter last year. As a group, sell-side analysts expect that Molina Healthcare, Inc will post 5.30 EPS for the current year.
About Molina Healthcare
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
Featured Stories
- Five stocks we like better than Molina Healthcare
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
